Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 28, 2026 07:00 ET | Source: Onco3R Therapeutics BV

Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline

Financing led by Sofinnova Investments and co-led by Forbion and Novo Holdings Proceeds to advance lead immunology program COL-5671, a potential first-in-class, oral once-daily therapy, across a...